Back
KalVista Pharmaceuticals Vs. Nuwellis Industry Stock Comparison
Buy
51
KALV
KalVista Pharmaceuticals
Last Price:
9.11
Seasonality Move:
13.48%
Sell
17
NUWE
Nuwellis
Last Price:
1.29
Seasonality Move:
-11.19%
Buy
51
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $9.44. The Score for KALV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- KALV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Nuwellis (NUWE)
is a Sell
Is Nuwellis a Buy, Sell or Hold?
- The current Nuwellis [NUWE] share price is $1.34. The Score for NUWE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NUWE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $9.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.
NUWE Stock Price Chart
KALV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 42.65 | Sell |
Chaikin Money Flow: | 86108 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.28 - 10.78) | Sell |
Bollinger Bands (100): | (10.14 - 13.18) | Sell |
NUWE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 46.24 | Sell |
Chaikin Money Flow: | 24121 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.22 - 1.76) | Sell |
Bollinger Bands (100): | (1.13 - 2.33) | Sell |
KALV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.65 | Sell |
20-day SMA: | 9.73 | Sell |
50-day SMA: | 10.83 | Sell |
200-day SMA: | 11.89 | Sell |
8-day EMA: | 9.58 | Sell |
20-day EMA: | 9.9 | Sell |
50-day EMA: | 10.56 | Sell |
200-day EMA: | 11.42 | Sell |
NUWE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.3 | Buy |
20-day SMA: | 1.41 | Sell |
50-day SMA: | 1.57 | Sell |
200-day SMA: | 5.88 | Sell |
8-day EMA: | 1.32 | Buy |
20-day EMA: | 1.41 | Sell |
50-day EMA: | 1.61 | Sell |
200-day EMA: | 32.12 | Sell |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.40 per share, and a decrease next year of $0.61 per share.
Nuwellis Earnings Growth & NUWE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.10 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nuwellis Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |